0001493152-20-014564.txt : 20200804 0001493152-20-014564.hdr.sgml : 20200804 20200804102628 ACCESSION NUMBER: 0001493152-20-014564 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200804 DATE AS OF CHANGE: 20200804 EFFECTIVENESS DATE: 20200804 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MATEON THERAPEUTICS INC CENTRAL INDEX KEY: 0000908259 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133679168 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-372407 FILM NUMBER: 201071670 BUSINESS ADDRESS: STREET 1: 29397 AGOURA RD. STREET 2: #107 CITY: AGUORA HILLS STATE: CA ZIP: 91301 BUSINESS PHONE: 650-635-7000 MAIL ADDRESS: STREET 1: 29397 AGOURA RD. STREET 2: #107 CITY: AGUORA HILLS STATE: CA ZIP: 91301 FORMER COMPANY: FORMER CONFORMED NAME: OXIGENE INC DATE OF NAME CHANGE: 19930628 D 1 primary_doc.xml X0708 D LIVE 0000908259 MATEON THERAPEUTICS INC 29397 AGOURA ROAD, SUITE 107 AGOURA HILLS CA CALIFORNIA 91301 650-635-7000 DELAWARE OXiGENE, Inc. OXIGENE INC Corporation true Vuong Trieu 29397 Agoura Road, Suite 107 Agoura Hills CA CALIFORNIA 91301 Executive Officer Director The above is the Chief Executive Officer of Mateon and the Chief Executive Officer and President of EdgePoint AI, Inc. Amit Shah 29397 Agoura Road, Suite 107 Agoura Hills CA CALIFORNIA 91301 Executive Officer The above is the Chief Financial Officer of Mateon and of EdgePoint AI, Inc. Chuho Park 29397 Agoura Road, Suite 107 Agoura Hills CA CALIFORNIA 91301 Executive Officer Biotechnology Decline to Disclose 06b false 2020-07-23 false true true true Offering of units consisting of (i) Mateon notes, which are convertible into Mateon common stock and EdgePoint common stock, (ii) EdgePoint common stock, and (iii) warrants to purchase Mateon common stock and EdgePoint common stock. false 50000 None 43520 JH Darbie & Co,. Inc. None 40 WALL STREET 30TH FLOOR NEW YORK NY NEW YORK 10005 AZ ARIZONA CA CALIFORNIA CO COLORADO CT CONNECTICUT MS MISSISSIPPI NV NEVADA NJ NEW JERSEY NY NEW YORK OR OREGON TN TENNESSEE false 5000000 2000000 3000000 true 0 24 256000 0 Mateon will pay JH Darbie & Co,. Inc. a sales commission equal to 10% of the gross amount of the proceeds received for the sale of all of the units. The above amount represents $200,000.00 for sales commissions and $56,00.00 for expenses. 0 false MATEON THERAPEUTICS INC /s/ Vuong Trieu Vuong Trieu CEO 2020-08-04